Clinical trials
Completed Observational Barrett Esophagus trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
54 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 2 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 6 |
| 2008 | 3 |
| 2009 | 2 |
| 2010 | 6 |
| 2011 | 5 |
| 2012 | 3 |
| 2013 | 5 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 6 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 54 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mayo Clinic | 15 |
| University of North Carolina, Chapel Hill | 4 |
| CDx Diagnostics | 3 |
| Columbia University | 2 |
| NinePoint Medical | 2 |
| Northwestern University | 2 |
| Portsmouth Hospitals NHS Trust | 2 |
| Abramson Cancer Center at Penn Medicine | 1 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 1 |
| Boston Scientific Corporation | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Barrett Esophagus | 54 |
| Gastroesophageal Reflux | 15 |
| Esophageal Neoplasms | 6 |
| Adenocarcinoma | 1 |
| Bronchial Neoplasms | 1 |
| Carcinoma | 1 |
| Deglutition Disorders | 1 |
| Eosinophilic Esophagitis | 1 |
| Esophageal Diseases | 1 |
| Esophageal Stenosis | 1 |
Trials
Showing 1 to 25 of 54. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.